Comparing tegoprazan and PPI for H. pylori treatment
Part of Digestive system, Infections clinical trials.
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 80 years old.
- You can have a gastroscopy (a tube with a camera placed into your stomach).
- You have not taken acid-reducing drugs (like omeprazole) or antibiotics in the last 2 weeks.
- You have never been treated for H. pylori before.
- You do not have severe anemia, advanced liver disease, or other serious illness.
- You have not had stomach surgery or a recent bleeding episode in your upper digestive tract.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests vonoprazan-based treatments to see if they can effectively clear H. pylori infection. It may help if you have not been treated for H. pylori before.
This study tests a new treatment plan using a medicine called tegoprazan for people with H. pylori, a bacteria that can cause stomach ulcers. The goal is to see if this sequential treatment works better at clearing the infection.
This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.
This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.
This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.
This trial tests different combinations of stomach acid-reducing drugs, vitamin D or probiotics, to see which works best for clearing an H. pylori infection. H. pylori is a common stomach bacteria that can cause ulcers or stomach discomfort.
Hear when a new H. Pylori Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.